|
|
Therapeutic Area: Cardiovascular
|
|
Disease State: Stroke Prevention in Atrial Fibrillation (SPAF)
Educational Objectives
- Highlight the under- recognized risk of stroke and/or inadequate prophylaxis in patients with atrial fibrillation and the associated morbidity, mortality, and cost burdens.
- Discuss strategies to incorporate clinical guidelines and quality measures into patient care to optimize outcomes of anticoagulation therapy.
- Discuss current and potential new challenges and opportunities in stroke prevention in atrial fibrillation.
- Describe the multifaceted role of thrombin and its contribution to the underlying pathophysiology that results in thromboembolic events.
- Enhance awareness and knowledge of current clinical and pharmacoeconomic research that adds to the body of scientific evidence and contributes to the care of patients with atrial fibrillation.
- Develop strategies to improve communication between HCPs and their patients/caregivers about the benefits and risks of anticoagulation therapy.
|
|